Resverlogix (RVX) Competitors

Microbix Biosystems (TSE:MBX) and Resverlogix (TSE:RVX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Which has stronger valuation and earnings, MBX or RVX?

Microbix Biosystems has higher revenue and earnings than Resverlogix. Resverlogix is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbix Biosystems	C$24.42M	1.59	C$3.39M	C$0.03	11.24
Resverlogix	N/A	N/A	-C$2.81M	-C$0.02	-2.23

Does the media prefer MBX or RVX?

In the previous week, Microbix Biosystems had 1 more articles in the media than Resverlogix. MarketBeat recorded 1 mentions for Microbix Biosystems and 0 mentions for Resverlogix. Microbix Biosystems' average media sentiment score of 0.99 beat Resverlogix's score of 0.00 indicating that Microbix Biosystems is being referred to more favorably in the media.

Company	Overall Sentiment
Microbix Biosystems	Positive
Resverlogix	Neutral

Which has more volatility & risk, MBX or RVX?

Microbix Biosystems has a beta of 0.34, suggesting that its stock price is 66% less volatile than the S&P 500. Comparatively, Resverlogix has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.

Do institutionals & insiders hold more shares of MBX or RVX?

0.4% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by insiders. Comparatively, 42.7% of Resverlogix shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Is MBX or RVX more profitable?

Microbix Biosystems has a net margin of 13.86% compared to Resverlogix's net margin of 0.00%. Microbix Biosystems' return on equity of 12.65% beat Resverlogix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbix Biosystems	13.86%	12.65%	3.82%
Resverlogix	N/A	6.06%	-34.90%

Summary

Microbix Biosystems beats Resverlogix on 10 of the 12 factors compared between the two stocks.